Douglas Elliman Inc
NYSE:DOUG
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Douglas Elliman Inc
Note Receivable
Douglas Elliman Inc
Note Receivable Peer Comparison
Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors
Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
D
|
Douglas Elliman Inc
NYSE:DOUG
|
Note Receivable
$36m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Jones Lang LaSalle Inc
NYSE:JLL
|
Note Receivable
$353.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
19%
|
|
C
|
Compass Inc
NYSE:COMP
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
CBRE Group Inc
NYSE:CBRE
|
Note Receivable
$173m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zillow Group Inc
NASDAQ:ZG
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Newmark Group Inc
NASDAQ:NMRK
|
Note Receivable
$787.9m
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
See Also
What is Douglas Elliman Inc's Note Receivable?
Note Receivable
36m
USD
Based on the financial report for Dec 31, 2023, Douglas Elliman Inc's Note Receivable amounts to 36m USD.
What is Douglas Elliman Inc's Note Receivable growth rate?
Note Receivable CAGR 3Y
15%
Over the last year, the Note Receivable growth was -7%. The average annual Note Receivable growth rates for Douglas Elliman Inc have been 15% over the past three years .